Our mission is to make Alzheimer's and other neurodegenerative disease detection accessible to people everywhere in the world even before the first symptoms arise, enabling early intervention of diseases and empowering doctors and patient.
At Neurognos we are working to change the outcome of Alzheimer’s disease by providing the right information at the right time. We are aiming to do this with our proprietary technology that let us identify the early indications of the disease even years before the first cognitives symptoms are detectable.
To ensure the quality and reliability of our results we are working with CLIA-certified laboratories, standardizing our procedures, automating our operations and systematizing our controls. All this just to offer the highest levels of precision possible.
Company Details
- Founded
- -
- Address
- Avenida Salvador 149, Cuarto Piso,chile
- al****@****nos.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neurognos.com
- Keywords
- Clinical Laboratory Service, Healthcare, Medical, Biotechnology, DiagnosticTesting, Technology, Big Data/ Data Mining, Alzheimer's disease, IVD.
- HQ
- Providencia, Santiago Metropolitan
Neurognos Questions
Neurognos's website is neurognos.com
Neurognos's LinkedIn profile is https://cl.linkedin.com/company/neurognos
Neurognos's industry is
Biotechnology Research
Neurognos's top competitors are
Mérieux Nutrisciences - Chile,
Alicanto Labs,
Biotecom Chile,
Kura Biotech,
James Lind,
Cdiem Chile,
Codebreaker Bioscience,
Biome Therapeutics Cl,
Solbio,
Clínica Elements.
Neurognos's support email address is alejandro@neurognos.com
Neurognos's categories are Biotechnology Research
Neurognos's founding year is 2016
